1. Introduction
===============

*Bufonis venonum* (BV), called Chan-Su in Chinese or Sum-So in Korean, is toad venom; in particular, it is the dried white secretions of the auricular and skin glands of the toads Bufo bufo gargarizans or Bufo melanosticus Schneider \[[@B001]-[@B003]\]. BV has detoxification, anti- inflammatory, cardiotonic, and pain-relief effects \[[@B001], [@B004]\], and studies on BV have reported local anesthetic actions and anti-cancer effects \[[@B005]-[@B008]\].

*Bufonis venonum* pharmacopuncture (BVP) is a pharmacopuncture that is produced by using various substances extracted from the toad venom. Choi *et al* \[[@B009]\] reported recently that BVP had therapeutic potential for treating neuropsychiatric disorders such as anxiety or depression disorder, but no side effects or toxicity of BVP have been reported so far. For that reason, we conducted an intramuscular single-dose toxicity test of BVP in Sprague-Dawley (SD) rats to determine the safety of its use safe and to estimating its appropriate dosage.

2. Materials and Methods
========================

Twenty-four SD rats of each gender were obtained from Orientbio Inc. (Gyeong-gi, Korea) at 5 weeks of age and were used after a week of quarantine and acclimatization. The animals were housed in a room maintained at 21.1 --- 24.1°C under a relative humidity of 40.7% --- 64.5%. The room was illuminated with artificial lighting from 07:00 to 19:00 hours and had 10 --- 15 air changes per hour. Three animals per cage were housed in suspended stainless-steel wire-mesh cages and were allowed sterilized tap water and commercial rodent chow (Teklad Certified Irradiated Global 18% Protein Rodent Diet 2918C, Harlan Laboratories, Inc., U.S.A.). This study protocol was approved by the institutional Animal Care Committee of Biotoxtech Co. (Oh Chang, Korea).

The BVP (Lot No. KPI-2013-01) was manufactured in a pathogen-free facility at the Korean Pharmacopuncture Institute, Seoul, Korea by using BV purchased from Shandong, China. Then, the pharmacopuncture with a concentration of 0.1 mg BV/mL was filtered through 0.1-μm filter paper. Finally, the BVP was sterilized before being used for this experiment.

Twenty healthy male and 20 healthy female SD rats were selected from among the original 48 SD rats and were assigned to 1 of 4 groups with five male and five female SD rats per group: control (normal saline at 0.5 mL/animal), low-dosage (BVP at 0.125 mL/animal), medium-dosage (BVP at 0.25 mL/animal) and high-dosage (BVP at 0.5 mL/animal) groups. BVP or normal saline (Lot No. 12133, Choongwae Pharma Corp., Korea) was administered to the rats by intramuscular injection in the left thigh.

All animals were observed for clinical signs at 30 minutes, 1 hour and 2 hours immediately after the injection and once a day, starting the day after injection, for 14 days. The body weight of each rat was measured at the beginning of treatment and at 3 days, 7 days and 14 days after the injection.

On day 15 after treatment, the animals were fasted for 18 hours prior to necropsy and blood collection. Blood samples were drawn from the abdominal aorta under isoflurane anesthesia by using a syringe needle. Blood samples were collected into tubes containing ethylenediaminetetraacetic acid (EDTA) and were analyzed to determine the red blood cell count (RBC), hemoglobin concentration (Hb), hematocrits (Ht), mean corpuscular cell volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular cell hemoglobin concentration (MCHC), platelet count, white blood cell count (WBC), differential WBC count, reticulocyte (Reti) count, prothrombin time (PT) and active partial thromboplastin time (APTT) by using Hematology Systems (ADVIA 2120i, Siemens, Munich, Germany).

For the serum biochemistry analysis, blood samples were centrifuged at 3,000 rpm for 10 minutes and analyzed by using an auto-analyzer (7180, Hitachi, Tokyo, Japan). Serum biochemistry parameters, including alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma glutamyl transpeptidase (GGT), blood urea nitrogen (BUN), creatinine, total bilirubin, total protein (TP), albumin, albumin/globulin ratio (A/G ratio), total cholesterol (T-Chol), triglycerides (TG), phosphate (P), glucose (Glu), calcium (Ca), chloride (Cl), sodium (Na) and potassium (K), were examined.

The tissues from the left thighs of the rats were routinely processed, embedded in paraffin and sectioned into 3- to 5-μm pieces. The sections were stained with hematoxylin and eosin (H&E) for microscopic examination. All tissues taken from all animals were examined microscopically.

Data on animal weights and on their blood chemistry and hematology were tested by using a statistical analysis system (SAS, version 9.3, SAS Institute, Inc., Cary, NC, U.S.A.). The variance in the numerical data was checked by using the Bartlett test. If the variance was homogeneous, the data were subjected to a one-way analysis of variance (ANOVA). If either of the tests showed a significant difference among the groups, the data were analyzed using the multiple comparison procedure of the Dunnett test. If not, they were analyzed using the Kruskal-Wallis non-parametric ANOVA test (*P* \< 0.05).

3. Results
==========

No treatment-related mortalities, clinical signs or weight changes occurred in either the control animals or the animals treated with any dose of BVP during the observation period (Tables [1](#T001){ref-type="table"},[2](#T002){ref-type="table"}). On the hematological examination (Table [3](#T003){ref-type="table"}), one female in the medium-dosage group showed a significant change; however, the change was not dose-dependent; the change seemed to have occurred sporadically. The blood chemistry tests (Table [4](#T004){ref-type="table"}) showed no significant changes.

The necropsy examinations (Tables [5](#T005){ref-type="table"},[6](#T006){ref-type="table"}) showed no abnormalities. Moreover, on the histopathological examination, one male in the control group and one female in the low-dosage group showed abnormal changes, but those changes were not dose-dependent. Thus, they were deemed not be important toxicological changes.

4. Discussion
=============

BV has some toxic ingredients that can induce serious effects, including bradycardia, atrioventricular conduction block, ventricular tachycardia, ventricular fibrillation, and sudden death \[[@B010]\]. Bufadienolides, such as bufalin, cinobufagin and resibufogenin, which are major sources of BV, are known to increase vasoconstriction, vascular resistance and blood pressure probably by inhibiting Na, K-adenosine triphosphate (ATP) ase activity \[[@B011], [@B012]\], and these substances have recently been reported to have a strong surface anesthetic activity, cytotoxic effect and differentiation- apoptosis activity on murine leukemia human acute promyeocytic leukemia (HL-60) cells \[[@B013]\]. In addition, BV includes bufotenine, an indole alkaloid that produces effects such as aphrodisia and hallucination, and serotonin, which is involved in various psychiatric disorders such as depression, anxiety, chronic obsession syndrome and impulsivity \[[@B014]-[@B016]\]. Thus, appropriate dosage and careful use are very important for the safe use of BV \[[@B002]\].

For the above reasons, we conducted an intramuscular single-dose toxicity test of BVP in SD rats to determine an appropriate dosage for its safe use. The results showed no treatment-related abnormalities for any of the used doses of BVP. The dose used for the high-dosage group was 0.5 mL/animal, and no dangerous signs were observed. Thus, we may conclude that 0.5 mL/animal of BVP is a safe dose in both male and female SD rats.

5. Conclusion
=============

This study showed that the lethal dose of BVP was over 0.5 mL/animal in both male and female SD rats.

###### Summary of mortalities

  Sex          Group / Dose   No. ofanimals   Days after dosing   Mortality                                                           
  ------------ -------------- --------------- ------------------- ----------- --- --- ---- --- --- ---- --- --- --- --- --- --- ----- -----
  Male         G1(0)          5               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0     0/5
  G2 (0.125)   5              0               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0/5   
  G3 (0.25)    5              0               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0/5   
  G4 (0.5)     5              0               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0/5   
  Female       G1(0)          5               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0     0/5
  G2 (0.125)   5              0               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0/5   
  G3 (0.25)    5              0               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0/5   
  G4 (0.5)     5              0               0                   0           0   0   0    0   0   0    0   0   0   0   0   0   0/5   

###### Mean body weights

  ----------------------------------------------------------------------------------------
  Sex       Group / Dose\   Mean    Days after dosing   Gain (g)                   
            (mL/animal)\                                                           
  --------- --------------- ------- ------------------- ---------- ------- ------- -------
  Male      G1\             Mean    191.5               219.1      255.3   315.4   123.9
            (0)                                                                    

  S.D.      4.8             6.7     10.3                17.9       13.6            

  N         5               5       5                   5          5               

  G2\       Mean            190.0   217.9               256.1      314.7   124.7   
  (0.125)                                                                          

  S.D.      5.5             5.4     9.5                 15.3       10.6            

  N         5               5       5                   5          5               

  G3\       Mean            188.8   214.0               250.2      309.6   120.8   
  (0.25)                                                                           

  S.D.      3.0             4.3     6.3                 9.0        7.1             

  N         5               5       5                   5          5               

  G4\       Mean            189.9   216.0               254.7      318.5   128.5   
  (0.5)                                                                            

  S.D.      6.7             9.1     11.5                16.9       11.2            

  N         5               5       5                   5          5               

  Female    G1\             Mean    157.3               173.0      192.0   220.5   63.2
            (0)                                                                    

  S.D.      8.3             11.7    15.5                18.8       12.0            

  N         5               5       5                   5          5               

  G2\       Mean            159.1   175.3               192.4      218.0   58.9    
  (0.125)                                                                          

  S.D.      1.8             3.2     7.5                 9.6        11.2            

  N         5               5       5                   5          5               

  G3\       Mean            157.0   173.3               192.7      220.6   63.6    
  (0.25)                                                                           

  S.D.      8.5             7.8     8.5                 12.5       4.5             

  N         5               5       5                   5          5               

  G4\       Mean            157.0   172.1               187.1      212.8   55.8    
  (0.5)                                                                            

  S.D.      7.4             8.1     10.9                14.9       9.2             

  N         5               5       5                   5          5               
  ----------------------------------------------------------------------------------------

S.D., standard deviation; N, number of animals.

###### Mean hematology parameters

  Sex            Group /Dose(mL/animal)   Mean    RBC (× 10^6^cells/μL)   HGB(g/dL)   HCT(%)   RBC Indices   PLT (× 10^3^cells/μL)   Reti(%)   WBC (× 10^6^cells/μL)   WBC Differential Counting (%)   PT(sec)   APTT(sec)                                         
  -------------- ------------------------ ------- ----------------------- ----------- -------- ------------- ----------------------- --------- ----------------------- ------------------------------- --------- ----------- ------- ------ ------ ------- ------- -------
  Male           G1(0)                    Mean    7.23                    14.8        42.4     58.6          20.5                    34.9      1235                    4.52                            8.29      18.7        78.4    1.4    0.6    0.1     16.6    12.9 
  S.D.           0.10                     0.4     1.2                     1.9         0.7      0.9           138                     0.82      2.35                    4.2                             3.9       0.3         0.2     0.1    0.9    2.6             
  N              5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               
  G2(0.125)       Mean                    7.56    15.3                     44.2       58.4      20.2          34.5                   1215      3.96                    7.71                            14.7      82.3        1.8     0.5    0.2    17.6    14.0    
  S.D.           0.25                     0.4     1.7                     1.2         0.4      0.5           92                      0.58      1.28                    1.9                             2.0       0.5         0.2     0.1    1.2    2.0             
  N              5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               
  G3(0.25)       Mean                     7.32    14.8                     42.5       58.0      20.2          34.8                   975       3.97                    7.62                             17.4     79.8        1.6     0.4    0.2     16.8    13.8   
  S.D.           0.30                     0.6     1.7                     0.8         0.4      0.6           239                     0.43      2.28                    6.9                             6.7       0.4         0.2     0.1    0.7    1.9             
  N              5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               
  G4(0.5)        Mean                     7.34    14.9                    43.4        59.2     20.3          34.3                    1083      4.82                    9.32                            16.2      81.1        1.6     0.5    0.1    16.2    12.4    
  S.D.           0.27                     0.5     1.6                     1.7         0.7      0.4           142                     0.78      2.24                    3.1                             3.4       0.4         0.1     0.1    0.3    1.9             
  N              5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               
  Female         G1(0)                    Mean    7.72                    15.5        42.8     55.4          20.0                    36.1      1125                    2.55                            5.24      15.3        80.9    1.6    1.6    0.1     18.4     14.8
  S.D.           0.16                     0.5     1.5                     1.5         0.4      0.2           182                     0.14      1.25                    5.7                             6.8        0.8        0.4     0.1     0.3   1.4             
  N               5                       5       5                       5           5        5             5                       5         5                       5                               5         5           5       5       5     5               
  G2(0.125)      Mean                     7.63    15.4                    42.9        56.3     20.2          35.9                    1027      2.25                     4.83                            10.7     85.8        1.5     1.0    0.2    17.8    13.4    
  S.D.            0.25                    0.4     1.4                     1.9         0.6      0.5           104                     0.50      1.05                    1.7                             1.2       0.5         0.2     0.1     0.3   1.8             
  N              5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               
  G3(0.25)       Mean                     7.22    14.6^\*^                40.6        56.3     20.2          35.9                    1044      2.47                    6.08                            12.9      83.8         1.3    1.1    0.2    17.7    14.7    
  S.D.            0.36                    0.7     1.8                     2.1         0.9      0.4           327                     0.28      3.63                    6.0                             6.5       0.4         0.5     0.1     1.2   0.6             
  N              5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               
  G4(0.5)        Mean                      7.61   15.3                    42.6        55.7     20.0          35.9                    1078      2.03                    6.05                            12.1      84.4        1.5     1.1    0.2    17.8    15.3    
  S.D.            0.34                    0.4     1.0                     2.1         1.0      0.4           90                      0.37      2.40                    1.9                             2.2       0.3         0.3     0.0    0.9    1.5             
   N             5                        5       5                       5           5        5             5                       5         5                       5                               5         5           5       5      5      5               

Significantly different from control by Dunnett's *t*-test:^\*^*P* \< 0.05. S.D., standard deviation; N, number of animals; RBC, red blood cell; HGB, hemoglobin; HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration; PLT, platelet; Reti, reticulocytes; WBC, white blood cell; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; EOS, Eosinophils; BASO, basophils; PT, prothrombin time; APTT, activated partial thromboplastin time.

###### Mean clinical chemistry

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sex               Group /Dose(mL/animal)   Mean    ALT(U/L)   AST(U/L)   ALP(U/L)   GGT(U/L)   Glu(mg/dL)   BUN(mg/dL)   Crea(mg/dL)   T-Bili(mg/dL)   T-Chol(mg/dL)   TG(mg/dL)   TP(mg/dL)   Alb(mg/dL)   A/Gratio   P(mg/dL)   Ca(mg/dL)   Na(mmol/L)   K(mmol/L)   CI(mmol/L)
  ----------------- ------------------------ ------- ---------- ---------- ---------- ---------- ------------ ------------ ------------- --------------- --------------- ----------- ----------- ------------ ---------- ---------- ----------- ------------ ----------- ------------
  Male              G1\                      Mean    30.0       92.1       937.3      0.41       113          12.2         0.41          0.03            70              37          5.4         2.3          0.76       8.70       9.7         140          4.8         105 
                    (0)                                                                                                                                                                                                                                                  

  S.D.              2.2                      12.2    176.7      0.08       15         1.1        0.01         0.03         6             16              0.2             0.1         0.03        0.66         0.3        0          0.6         2                        

  N                 5                        5       5          5          5          5          5            5            5             5               5               5           5           5            5          5          5           5                        

  G2\               Mean                     32.1    107.3      851.6      0.39       116        11.8         0.39         0.02          66              40              5.4         2.3         0.76         8.69        10.0       139         4.6         105         
  (0.125)                                                                                                                                                                                                                                                                

  S.D.              4.2                      22.0    174.7      0.05       12         1.0        0.02         0.01         15            24              0.3             0.1         0.05        0.57          0.4        0         0.2         1                        

  N                 5                        5       5          5          5          5          5            5            5             5               5               5           5           5            5          5          5           5                        

  G3\               Mean                     32.3    105.6      917.2      0.41       109        12.8         0.40         0.01          68               33             5.3         2.3         0.76         8.55       9.9         139        4.4          105         
  (0.25)                                                                                                                                                                                                                                                                 

  S.D.              4.5                      22.3    117.0      0.14       18         2.3        0.04         0.01         19             16             0.0             0.1         0.04        0.38         0.2        1          0.2         1                        

  N                 5                        5       5          5          5          5          5            5            5             5               5               5           5           5            5          5          5           5                        

  G4\                Mean                    28.5    118.6      777.7      0.45       117        12.2         0.40         0.02          69               37             5.2         2.3         0.80         8.65       9.7        139         4.6          105         
  (0.5)                                                                                                                                                                                                                                                                  

   S.D.             3.2                      15.3    169.7      0.12       8          0.8        0.02         0.01         18             13              0.1             0.1        0.09         0.28         0.2       1          0.5         1                        

   N                 5                       5       5          5          5          5          5            5            5             5               5               5           5           5            5           5         5           5                        

  Female            G1\                       Mean   26.8       90.3       572.4      0.65       116          13.2         0.42          0.01            77              16          5.8         2.6          0.83       7.11       9.9         140          4.6         106
                    (0)                                                                                                                                                                                                                                                  

   S.D.             1.6                      10.1     196.5     0.21       3          1.0        0.02         0.01         13            7               0.3             0.1         0.04        0.50         0.2        1          0.1          2                       

  N                  5                        5       5          5         5           5         5            5            5             5               5               5           5           5             5         5          5            5                       

  G2\                Mean                    24.1    90.3       456.9      0.52       117        13.7         0.41         0.01           76              13             5.8         2.7          0.87        7.49       10.0       140         4.5          106         
  (0.125)                                                                                                                                                                                                                                                                

   S.D.             3.7                      20.5    90.9       0.22       7          1.5        0.03         0.01          10            3              0.2              0.1        0.04        0.32         0.1        1          0.3          2                       

  N                 5                         5       5         5          5          5          5            5            5             5               5               5           5           5             5         5          5            5                       

  G3\                Mean                    22.1    94.8       531.7      0.60       118        11.8         0.43         0.01          89              16              5.7         2.6         0.83         7.57       9.8        140         4.5          106         
  (0.25)                                                                                                                                                                                                                                                                 

   S.D.             3.8                      27.1     101.4     0.11       4          1.3        0.02         0.00         15            6               0.5             0.3         0.05        0.64         0.5        1          0.5         2                        

  N                  5                        5       5         5          5          5          5            5            5             5               5               5           5           5             5         5          5           5                        

  G4\                Mean                     24.6    93.3      543.8      0.52       118        14.7         0.45         0.01           92              18              5.6        2.5         0.83         7.83       9.8        140         4.5           107        
  (0.5)                                                                                                                                                                                                                                                                  

   S.D.              3.1                     12.1    150.3       0.17      5          3.2        0.04         0.01          8            2                0.1            0.1         0.04        0.27         0.2        1          0.3          1                       

  N                  5                        5       5         5          5          5          5            5            5             5               5               5           5           5             5         5           5           5                       
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

S.D., standard deviation; N, number of animals; ALT, alanine aminotransferase; AST, aspartate aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutamyl transpeptidase; Glu, glucose; BUN, blood urea nitrogen; Crea, creatinine; T-Bili, total bilirubin; T-Chol, total cholesterol; TG, triglycerides; TP, total protein; Alb, albumin; A/G ratio, albumin/globulin ratio; P, phosphorus; Ca, calcium; Na, sodium; K, potassium; Cl, chloride.

###### Summary of necropsy findings

  Sex                     Male   Female                                    
  ----------------------- ------ -------- ------ ----- ---- ------- ------ -----
  Group                   G1     G2       G3     G4    G1   G2      G3     G4
  Dose (mL/animal)        0      0.125    0.25   0.5   0    0.125   0.25   0.5
  No. of animals          5      5        5      5     5    5       5      5
  Unremarkable findings   5      5        5      5     5    5       5      5
  No. of rats examined    5      5        5      5     5    5       5      5

External surface and all organs in the body cavity were unremarkable.

###### Summary of histopathological findings

  ---------------------------------------------------------------------------------------------------------------------------------------------------
  Sex                                      Male                                      Female                                                      
  ---------------------------------------- ----------------------------------------- -------- ------- ------ ----- ---- --- ------- ------ ----- ----
  Organ /\                                 Group                                              G1      G2     G3    G4       G1      G2     G3    G4
  Findings                                                                                                                                       

  Dose (mL/animal)                                                                   0        0.125   0.25   0.5        0   0.125   0.25   0.5   

  No. of animals                                                                     5        5       5      5          5   5       5      5     

  Injection site                           -Cell infiltration, inflammatory, focal   ±        1       0      0     0    ±   0       1      0     0

  -Cell infiltration, macrophages, focal                                                                           ±    0   1       0      0     
  ---------------------------------------------------------------------------------------------------------------------------------------------------

Grade- ±, minimal.
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